Your browser doesn't support javascript.
loading
Variability in Breast Density Estimation and Its Impact on Breast Cancer Risk Assessment.
Ji, Hye; Jang, Myoung-Jin; Chang, Jung Min.
Afiliação
  • Ji H; Department of Radiology, Seoul National University Hospital, Seoul, Korea.
  • Jang MJ; Medical Research Collaborating Center, Seoul National University Hospital, Seoul, Korea.
  • Chang JM; Department of Radiology, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea. imchangjm@gmail.com.
J Breast Cancer ; 2024 Aug 12.
Article em En | MEDLINE | ID: mdl-39344408
ABSTRACT
Breast density is an independent risk factor for breast cancer, although variability exists in measurements. This study sought to evaluate the agreement between radiologists and automated breast density assessment software and assess the impact of breast density measures on breast cancer risk estimates using the Breast Cancer Surveillance Consortium (BCSC) model (v.2). A retrospective database search identified women who had undergone mammography between December 2021 and June 2022. The Breast Imaging Reporting and Data System (BI-RADS) breast composition index assigned by a radiologist (R) was recorded and analyzed using three commercially available software programs (S1, S2, and S3). The agreement rate and Cohen's kappa (κ) were used to evaluate inter-rater agreements concerning breast density measures. The 5-year risk of invasive breast cancer in women was calculated using the BCSC model (v.2) with breast density inputs from various density estimation methods. Absolute differences in risk between various density measurements were evaluated. Overall, 1,949 women (mean age, 53.2 years) were included. The inter-rater agreement between R, S1, and S2 was 75.0-75.6%, while that between S3 and the others was 60.2%-63.3%. Kappa was substantial between R, S1, and S2 (0.66-0.68), and moderate (0.49-0.50) between S3 and the others. S3 placed fewer women in mammographic density d (14.9%) than R, S1, and S2 (40.5%-44.0%). In BCSC risk assessment (v.2), S3 assessed fewer women with a high 5-year risk of invasive breast cancer than the other methods, resulting in an absolute difference of 0% between R, S1, and S2 in 75.0%-75.6% of cases, whereas the difference between S3 and the other methods occurs in 60.2%-63.3% of cases. Breast density assessment using various methods showed moderate-to-substantial agreement, potentially affecting risk assessments. Precise and consistent breast density measurements may lead to personalized and effective strategies for breast cancer prevention.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Breast Cancer Ano de publicação: 2024 Tipo de documento: Article País de publicação:

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Idioma: En Revista: J Breast Cancer Ano de publicação: 2024 Tipo de documento: Article País de publicação: